TY - JOUR
T1 - Costs associated with acute respiratory illness and select virus infections in hospitalized children, El Salvador and Panama, 2012-2013
AU - Jara, Jorge H
AU - Azziz-Baumgartner, Eduardo
AU - De Leon, Tirza
AU - Luciani, Kathia
AU - Brizuela, Yarisa Sujey
AU - Estripeaut, Dora
AU - Castillo, Juan Miguel
AU - Barahona, Alfredo
AU - Corro, Mary
AU - Cazares, Rafael
AU - Vergara, Ofelina
AU - Rauda, Rafael
AU - González, Rosalba
AU - Franco, Danilo
AU - Widdowson, Marc-Alain
AU - Clará, Wilfrido
AU - Alvis-Estrada, Juan P
AU - Murray, Christian Travis
AU - Ortega-Sanchez, Ismael R
AU - Dawood, Fatimah S
N1 - FTX; (CC BY-NC-ND 4.0) Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.
PY - 2019
Y1 - 2019
N2 - Background and objectives: Although acute respiratory illness (ARI) is a leading cause of hospitalization among young children, few data are available about cost of hospitalization in middle-income countries. We estimated direct and indirect costs associated with severe ARI resulting in hospitalization among children aged <10 years in El Salvador and Panama through the societal perspective.Methods: During 2012 and 2013, we surveyed caregivers of children hospitalized with ARI about their direct medical (i.e., outpatient consultation, medications, hospital fees), non-medical (transportation, childcare), and indirect costs (lost wages) at discharge and 7 days after discharge. We multiplied subsidized hospital bed costs derived from administrative data by hospitalization days to estimate provider costs.Results: Overall, 638 children were enrolled with a median age of 12 months (IQR 6-23). Their median length of hospitalization was 4 days (IQR 3-6). In El Salvador, caregivers incurred a median of US$38 (IQR 22-72) in direct and indirect costs per illness episode, while the median government-paid hospitalization cost was US$118 (IQR 59-384) generating an overall societal cost of US$219 (IQR 101-416) per severe ARI episode. In Panama, caregivers incurred a median of US$75 (IQR 39-135) in direct and indirect costs, and the health-care system paid US$280 (IQR 150-420) per hospitalization producing an overall societal cost of US$393 (IQR 258-552).Conclusions: The cost of severe ARI to caregivers and the health care system was substantive. Our estimates will inform models to estimate national costs of severe ARI and cost-benefit of prevention and treatment strategies.
AB - Background and objectives: Although acute respiratory illness (ARI) is a leading cause of hospitalization among young children, few data are available about cost of hospitalization in middle-income countries. We estimated direct and indirect costs associated with severe ARI resulting in hospitalization among children aged <10 years in El Salvador and Panama through the societal perspective.Methods: During 2012 and 2013, we surveyed caregivers of children hospitalized with ARI about their direct medical (i.e., outpatient consultation, medications, hospital fees), non-medical (transportation, childcare), and indirect costs (lost wages) at discharge and 7 days after discharge. We multiplied subsidized hospital bed costs derived from administrative data by hospitalization days to estimate provider costs.Results: Overall, 638 children were enrolled with a median age of 12 months (IQR 6-23). Their median length of hospitalization was 4 days (IQR 3-6). In El Salvador, caregivers incurred a median of US$38 (IQR 22-72) in direct and indirect costs per illness episode, while the median government-paid hospitalization cost was US$118 (IQR 59-384) generating an overall societal cost of US$219 (IQR 101-416) per severe ARI episode. In Panama, caregivers incurred a median of US$75 (IQR 39-135) in direct and indirect costs, and the health-care system paid US$280 (IQR 150-420) per hospitalization producing an overall societal cost of US$393 (IQR 258-552).Conclusions: The cost of severe ARI to caregivers and the health care system was substantive. Our estimates will inform models to estimate national costs of severe ARI and cost-benefit of prevention and treatment strategies.
U2 - 10.1016/j.jinf.2019.05.021
DO - 10.1016/j.jinf.2019.05.021
M3 - A1: Web of Science-article
C2 - 31153920
SN - 0163-4453
VL - 79
SP - 108
EP - 114
JO - Journal of Infection
JF - Journal of Infection
IS - 2
ER -